Sign up here for our live event! Hear the latest on the race for a coronavirus vaccine and the 'return to normal' from 3 leading experts.
Summary List Placement
Coronavirus vaccines have progressed extraordinarily quickly in reaching the final stages of clinical testing, supporting the possibility that hundreds of millions of doses could be administered in 2021. A vaccine is widely acknowledged as a crucial element in exiting this pandemic. But in order to truly help society, a vaccine needs to be safe, effective and widely available. Business Insider's healthcare reporter Andrew Dunn will discuss the road ahead for coronavirus vaccines on October 5th at 2:00 p.m. ET. In this live webinar, Dunn will talk with three leading vaccine experts: Maria Elena Bottazzi, co-director of Texas Children's Hospital Center for Vaccine Development and associate dean of Baylor College of Medicine's National School of Tropical Medicine, Art Caplan, a bioethicist and founding head of the Division of Medical Ethics at New York University School of Medicine, and Dr. William Haseltine, infectious-disease expert and chair and president of ACCESS Health International. The panel will discuss what it takes to get a vaccine candidate across the finish line and what happens after that. Even with a safe and effective vaccine, drugmakers and governments will need to collaborate on plans for mass-production, fairly distributing the shot, and convincing the public to get vaccinated. Leading experts will weigh in on the latest challenges and how they are being tackled.
If you're a Business Insider subscriber, you can sign up here. Join the conversation about this story » NOW WATCH: Why NASA won't send humans to Venus
More like this (3)
This weekend, the FDA authorized another vaccine for COVID-19, bringing the total number of options in...This weekend, the FDA authorized another vaccine for COVID-19, bringing the total number of options in the US up to three. While there are subtle differences between the three vaccines, all of them appear to be safe and effective, and experts recommend that you get whichever one you can. Read more...
J&J's one-dose coronavirus vaccine just won a critical thumbs-up from an FDA panel, paving the way for US authorization
Summary List PlacementJohnson & Johnson's experimental coronavirus vaccine just passed a critical hurdle, as a group...Summary List PlacementJohnson & Johnson's experimental coronavirus vaccine just passed a critical hurdle, as a group of top doctors and scientists voted unanimously on Friday to endorse the shot. After the vote, the Food and Drug Administration said it would work quickly to authorize the vaccine, allowing it to be given more widely. J&J has said it will have nearly 4 million doses ready...
US expert Dr Anthony Fauci says it should be known by early December if vaccine is...US expert Dr Anthony Fauci says it should be known by early December if vaccine is safe to roll outCoronavirus – latest updatesSee all our coronavirus coverageHopes are rising that a coronavirus vaccine will be approved by the end of the year, with healthcare workers receiving their first dose in early 2021.Dr Anthony Fauci, the US’s leading expert in infectious diseases, said on Sunday...